Cancer: Medical Treatments
Commons · Question 24545 · Tabled 28 Aug 2026 · Department of Health and Social Care · Official record
Answered 21 Sep 2026
Question
Asked by Zubir Ahmed
To ask the Secretary of State for Health and Social Care, what assessment she has made of the risks to patients arising from the promotion and sale online of ivermectin and other unlicensed or unproven products as treatments for cancer; and what steps the
Answer
Answered by James Frith, 21 Sep 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) recognises the risks associated with the promotion and sale of ivermectin and other unauthorised or unproven products as treatments for cancer. Ivermectin is not authorised in the United Kingd...